CLX Investment Company Announces Zonda to Exhibit at MEDICA -- The World's Largest Medical Trade Event.

TEMECULA, Calif. -- CLX Investment Company Inc. (OTCBB:CLXN) today announced that portfolio investment Zonda Inc. will be an exhibitor at MEDICA, the world's largest medical trade fair, which will be held on Nov. 16-19 in Dusseldorf, Germany. The MEDICA trade fair, titled the 37th World Forum for Medicine (www.medica.de), features 4,019 exhibitors and 136,152 visitors and the latest product developments from around the world.

"By exhibiting at MEDICA, Zonda will not only increase its visibility in medical supply circles, but with the pending launch of broader distribution of Zonda's products in markets through Europe, MEDICA is an opportunity for potential distribution partners to see the effectiveness of these products firsthand," commented Tammy Dunn, chief executive officer of CLX Investment Company. "There will be a large contingent of distributors in attendance at MEDICA, and as Zonda seeks to develop relationships with the strongest distribution partners in every market it enters, this event will provide an opportunity to speak directly with distribution candidates from all continents."

Zonda Inc., a privately held company that specializes in test products that serve the medical diagnostic (IVD), food safety, and sanitation testing markets, is preparing to expand the distribution of its product lines into broader markets around the world, beginning with a focus in Europe.

The first product that has been targeted for increased European marketing and distribution efforts is an innovative, rapid, self-contained diagnostic device for the detection of Chlamydia, which has been given a CE mark for professional and over-the-counter use, to markets throughout Europe. The device, which is marketed under the HandiLab name, is superior to its competition due to its comparable accuracy (compared directly to PCR testing), ease of use, compact design, long shelf life, rapid results, and cost effectiveness.

MEDICA's exhibit range includes electromedical equipment, medical technology, laboratory equipment, rescue and emergency equipment, diagnostics, drugs, physiotherapy, orthopedic technology, single-use products and consumer goods.

"In addition to attracting the attention of distributors at this event, MEDICA attendees will include large numbers of potential end users of the HandiLab products, such as hospitals, laboratories, and medical clinics. We expect that a wide variety of customers for medical diagnostic testing products will be intensely interested in the Zonda product lines," added Dunn. "As we support Zonda's growth through both financing and management support, there may also be opportunities to invest in other similar companies that have tremendous potential, but lack the resources to successfully penetrate worldwide markets," stated Dunn.

To sign up to receive information by e-mail directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.asp.

About CLX Investment Company

CLX Investment Company (www.clxinvestments.com) has elected to be regulated as a Business Development Company pursuant to Section 54 of the Investment Company Act of 1940, and is pursuing a business plan wherein the company seeks to make investment in developing companies with the goal of providing return for its shareholders.

CLX has acquired a 49 percent interest in eStrategy Solutions Inc. (www.clxinvestments.com/estrategysolutions), a Texas-based e-learning provider that has developed online training solutions for government entities and other professional organizations. The company has made an investment in ActionView International Inc. (www.actionviewinternational.com), a publicly traded manufacturer of scrolling advertising billboards. CLX holds a 20 percent equity interest in Zonda Inc. (www.zondainc.com), a privately held company that specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.